(Q48031726)

English

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison

scientific article published in June 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

0 references

Plasmodium falciparum

0 references

0 references

Nicholas John White

12

object named as

Nicholas J White

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

Kasia Stepniewska

11

object named as

Kasia Stepniewska

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

Elizabeth Dodds Ashley

9

object named as

Elizabeth Ashley

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

author name string

Frank Smithuis

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

Moe Kyaw Kyaw

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

Ohn Phe

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

Khin Zarli Aye

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

Lhin Htet

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

Marion Barends

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

Niklas Lindegardh

7

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

Thida Singtoroj

8

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

Saw Lwin

10

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

language of work or name

0 references

publication date

1 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

367

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

9528

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

2075-2085

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

Mefloquine-resistant falciparum malaria on the Thai-Burmese border

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Automated solid-phase extraction method for the determination of piperaquine in capillary blood applied onto sampling paper by liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of artemisinin derivatives on malaria transmissibility

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Interval estimation for the difference between independent proportions: comparison of eleven methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Population pharmacokinetics of mefloquine in patients with acute falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mixed-species malaria infections in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of malaria in a Karen population on the western border of Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

How do patients use antimalarial drugs? A review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968931-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(06)68931-9

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/16798391

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48031726&oldid=2212667668"